Cancer News
Improving Care: New UK Guidance

In NEJM, Clues to Which Melanomas Respond to Immunotherapy

Survival in Melanoma Ups Further: 'We Have Cure in Our Sights'

Germline Genetics in Cancer: From Screening to Treatment

Crizotinib Highly Active in ROS1-Mutated Lung Cancer
Wide variation found in quality, content of clinical cancer guidelines

Power behind 'master' gene for cancer discovered

Hookah smoke increases benzene exposure, risk for leukemia

Snus use in Norway has tripled in five years

Key factor discovered in the progression of liver cancer
Get Ready for the Great American Smokeout

Blue-Eyed People May Face Higher Melanoma Risk

Want to Raise Colon Cancer Screening Rates? Run a Lottery

Even With a Little Weight Gain, Quitting Smoking Is Still Healthier Choice

Medical Bills Pricey for Americans, Even With Private Insurance
UCLA Researchers Identify Unique Protein Key to the Development of Blood Stem Cells

UCLA Study Finds Ancient Chinese Exercise Lessens Inflammation in Breast Cancer Survivors

New Discovery by UCLA Researchers Could Lead to More Targeted Head and Neck Cancer Therapies

Patient Profile: Liana's Looms of Love

UCLA Vice Chancellor for Research Elected to Institute of Medicine
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: An open-label phase 1/2 study

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): A pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomised phase 3 trial

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: Final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma